Efficacy of the combination of levofloxacin plus ceftazidime in the treatment of hospital-acquired pneumonia in the Intensive Care Unit

International Journal of Antimicrobial Agents

Volumn 28, Issue 6, 2006, Pages 582-585

  Bassetti, M ^a   Righi, E ^a   Rosso, R ^a   Mannelli, S ^a   Di Biagio, A ^a   Fasce, R ^a   Pallavicini, F Bobbio ^a   Marchetti, F ^b   Viscoli, C ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b GSK   (Italy)

Author keywords

Ceftazidime; Hospital; Intensive Care Unit; Levofloxacin; Pneumonia

Indexed keywords

CEFTAZIDIME; LEVOFLOXACIN; VANCOMYCIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL INFECTION; HUMAN; HYPOTENSION; INDUCED HYPOTENSION; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; SKIN DISEASE; STAPHYLOCOCCUS INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

AGED; ANTI-BACTERIAL AGENTS; CEFTAZIDIME; CROSS INFECTION; DRUG THERAPY, COMBINATION; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; ITALY; MALE; MIDDLE AGED; OFLOXACIN; PNEUMONIA, BACTERIAL; TREATMENT OUTCOME;

EID: 33751198290     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.08.006     Document Type: Article

References (15)

1. Bruchhaus J.D., McEachern R., and Campbell Jr. G.D. Hospital-acquired pneumonia: recent advanced in diagnosis, microbiology and treatment. Curr Opin Pulm Med 4 (1998) 180-184
2. Chastre J., and Fagon J.Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med 165 (2002) 867-903
3. Niederman M.S. The clinical diagnosis of ventilator-associated pneumonia. Respir Care 50 (2005) 788-796
4. Michel F., Franceschini F., Berger P., et al. Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest 127 (2005) 589-597
5. Trouillet J.L., Chastre J., Vuagnat A., et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 157 (1998) 531-539
6. Shorr A.F., Zadekis N., Jackson W.L., et al. Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial. Clin Infect Dis 40 Suppl. 2 (2005) S123-S129
7. Visalli A., Jacobs M.R., and Appelbaum P.C. Activities of three quinolones, alone and in combination with extended-spectrum cephalosporin and gentamicin, against Stenotrophomonas maltophilia. Antimicrob Agents Chemother 42 (1998) 2002-2005
8. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 (2005) 388-416
9. Fagon J.Y., Chastre J., Wolff M., et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 132 (2000) 621-630
10. Jourdain B., Novara A., Joly-Guillou M.L., et al. Role of quantitative cultures of endotracheal aspirates in the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 152 (1995) 241-246
11. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Sixteenth Informational Supplement. New CLSI/NCCLS Antimicrobial Susceptibility Testing (AST) Recommendations, M100-S16 (2005), NCCLS, Wayne, PA
12. West M., Boulanger B.R., Fogarty C., et al. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study. Clin Ther 25 (2003) 485-506
13. Pea F., Viale P., and Furlanut M. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability. Clin Pharm 44 (2005) 1009-1034
14. Geddes A., Thaler M., Schonwald S., Harkonen M., Jacobs F., and Nowotny I. Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial. J Antimicrob Chemother 44 (1999) 799-810
15. Chastre J., Wolff M., Fagon J.Y., et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults. JAMA 290 (2003) 2588-2598